Whanganui Chronicle

Vaccine ‘safe and effective’

EU medicines agency gives Astrazenec­a jab go-ahead, leading some countries to resume shots as US reaches 100 million mark

-

TThis is a safe and effective vaccine. Its benefits in protecting people from Covid-19 with the associated risks of death and hospitalis­ation outweigh the possible risks.

EMA executive director Emer Cooke

he European Medicines Agency yesterday said the Astrazenec­a vaccine was “safe and effective”, paving the way for the EU to reboot its faltering rollout of the Oxford University jab.

France, Germany, Italy, Spain and 13 other EU countries have suspended the use of the vaccine amid fears of blood clots and against the advice from the bloc’s medicines watchdog.

“This is a safe and effective vaccine. Its benefits in protecting people from Covid-19 with the associated risks of death and hospitalis­ation outweigh the possible risks,” Emer Cooke, the EMA’S executive director, said.

Italy, Spain, Latvia, Lithuania, Luxembourg, German, the Netherland­s and Cyprus lifted the ban after the decision, and shots were resuming in some countries.

Slovenia’s prime minister was due to get the Oxford jab on camera after lifting the restrictio­ns. Jean Castex, the French prime minister, said he would also get the Astrazenec­a vaccine, and France would lift its suspension. He said Paris would be heading into a weekend lockdown.

More countries are expected to restart vaccinatio­ns after they said the suspension­s were a temporary precaution pending the EMA probe.

Sweden will make a decision next week.

“We have vaccines that are safe and effective that can help prevent death and hospitalis­ation. We need to use those vaccines,” Cooke said.

“The vaccine is not associated with an increase in the overall risk of thromboemb­olic events or blood clots.”

She added there was no evidence of a quality or batch issue.

The EU has vaccinated just 12 per cent of its population and used just under half of its stockpile of about 15 million Astrazenec­a jabs.

The EMA said there had been cases of “very rare and unusual but serious clotting disorders”, which it was not able to definitely rule out as linked to the Oxford jab. It said a warning would be added to product informatio­n for patients and doctors.

“I would be vaccinated tomorrow,” Cooke said, adding she hoped the investigat­ion would rebuild trust in the vaccine.

Emmanuel Macron, the French president, said he backed Ursula von der Leyen’s threat to impose an export ban on vaccines to the UK amid divides among European countries over the European Commission president’s plan to force Britain to send Uk-manufactur­ed Astrazenec­a jabs to the EU. She said on Wednesday the bloc could trigger Article 122 to block exports, seize factories and waive intellectu­al property rights.

Von der Leyen, who has been embroiled in a row with Astrazenec­a over supply shortfalls, said 10 million jabs manufactur­ed in the EU had been exported to Britain, but none had been sent from the UK to the bloc.

Germany, Italy and Denmark were supportive at a meeting of EU ambassador­s in Brussels yesterday. The Netherland­s, Belgium, Poland, Sweden and Ireland are concerned the move could hurt European supply chains and businesses.

Von der Leyen has spoken to Boris Johnson, who played down the idea the UK could retaliate to an EU vaccine export ban by blocking the export of vaccine components.

The Prime Minister said: “We will deliver all the second doses of the Pfizer. These vaccines are a multinatio­nal effort. We don’t have any bans on exporting stuff, and we will continue to cooperate with our European friends.”

Meanwhile, Joe Biden’s US administra­tion plans to send about 4 million doses of Astrazenec­a’s Covid-19 vaccine to neighbouri­ng Mexico and Canada.

Brussels wants the US to release 30 million Astrazenec­a doses for export, which are not being used because the US regulator has not approved the Oxford jab.

Biden also announced that, 58 days after taking office, his administra­tion would have administer­ed 100 million vacations. His goal had been to reach that total in 100 days.

“That’s way ahead of schedule,” he said.

 ?? Photo / AP ?? Countries in Europe are resuming Astrazenec­a jabs after a European Medicines Agency investigat­ion found the vaccine to be safe, after concerns over blood clots.
Photo / AP Countries in Europe are resuming Astrazenec­a jabs after a European Medicines Agency investigat­ion found the vaccine to be safe, after concerns over blood clots.

Newspapers in English

Newspapers from New Zealand